Annexon, Inc.(ANNX)
Biotechnology
Immunology & Autoimmune Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | Satter Muneer A Director | Purchase | +613,497 | +6.31%10,342,134 | $5.41 | $3,319,019 | View SEC filing | |
| 2026-05-13 | Carson William H. Director | Purchase | +8,000 | +11.36%78,405 | $5.78 | $46,240 | View SEC filing | |
| 2026-04-14 | Carson William H. Director | Purchase | +8,000 | +12.82%70,405 | $6.20 | $49,600 | View SEC filing | |
| 2026-03-12 | Carson William H. Director | Purchase | +8,000 | +14.70%62,405 | $5.67 | $45,360 | View SEC filing | |
| 2026-03-04 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Sale | -5,894 | -3.17%180,093 | $5.43 | $32,004 | View SEC filing | |
| 2026-03-04 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | -5,566 | -3.48%154,161 | $5.42 | $30,168 | View SEC filing | |
| 2026-03-04 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | -4,339 | -2.32%182,625 | $5.42 | $23,517 | View SEC filing | |
| 2026-03-04 | Dananberg Jamie CHIEF MEDICAL OFFICER | Sale | -5,820 | -4.50%123,582 | $5.43 | $31,603 | View SEC filing | |
| 2026-03-04 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | -5,565 | -3.16%170,700 | $5.42 | $30,162 | View SEC filing | |
| 2026-02-20 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Sale | -5,290 | -4.11%123,487 | $5.10 | $26,979 | View SEC filing | |
| 2026-02-20 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | -7,857 | -7.48%97,227 | $5.11 | $40,149 | View SEC filing | |
| 2026-02-20 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | -6,225 | -4.76%124,464 | $5.10 | $31,748 | View SEC filing | |
| 2026-02-20 | Dananberg Jamie CHIEF MEDICAL OFFICER | Sale | -5,290 | -6.74%73,152 | $5.10 | $26,979 | View SEC filing | |
| 2026-02-20 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | -7,851 | -6.46%113,765 | $5.11 | $40,119 | View SEC filing | |
| 2026-01-02 | Carson William H. Director | Purchase | +4,115 | +8.18%54,405 | $5.02 | $20,657 | View SEC filing | |
| 2025-12-03 | Carson William H. Director | Purchase | +4,115 | +8.91%50,290 | $4.47 | $18,394 | View SEC filing | |
| 2025-12-03 | Choi Jung Director | Purchase | +33,000 | +100.00%33,000 | $4.19 | $138,270 | View SEC filing | |
| 2025-11-21 | Satter Muneer A Director | Purchase | +822,613 | +9.24%9,728,637 | $4.38 | $3,600,784 | View SEC filing | |
| 2025-11-19 | Satter Muneer A Director | Purchase | +1,500,000 | +20.25%8,906,024 | $3.37 | $5,055,000 | View SEC filing | |
| 2025-10-31 | Carson William H. Director | Purchase | +4,115 | +9.78%46,175 | $3.17 | $13,045 | View SEC filing | |
| 2025-10-02 | Carson William H. Director | Purchase | +4,115 | +10.84%42,060 | $3.05 | $12,551 | View SEC filing | |
| 2025-09-04 | Carson William H. Director | Purchase | +4,115 | +12.16%37,945 | $2.09 | $8,600 | View SEC filing | |
| 2025-08-01 | Carson William H. Director | Purchase | +4,115 | +13.85%33,830 | $2.43 | $9,999 | View SEC filing | |
| 2025-07-16 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | -1,116 | -1.05%105,084 | $2.58 | $2,879 | View SEC filing | |
| 2025-07-16 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | -1,117 | -0.91%121,616 | $2.58 | $2,882 | View SEC filing |
1-25 of 87